Delivery Order SPE2DB22D2007-SPE2DB25FH8BK

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,032.13, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $6,436.64 for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $26,703.15 delivery order contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,166.80, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has a completion date of January 6, 2025 and is a firm-fixed-price delivery order. This contract is not designated as a set-aside and is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $14,729.86 for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a firm fixed price of $13,089.53 and a completion date of November 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.90 firm-fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,823.66 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,946.70 firm fixed-price contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,757.80 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8BK
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,221.81, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, and has a completion date of January 8, 2025.

The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:57 AM